Time-dependent clinical outcomes of endovascular treatment in acute ischemic stroke due to middle cerebral artery M2 occlusion: A pooled analysis of three randomized controlled trials
Therapeutic Advances in Neurological Disorders · 2026-11 · 19
DOI: 10.1177/17562864261508450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Neurological Disorders, online erschienen am 13.11.2026. Verfasst von Xuexiao Zhao und 16 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China Young Scientists Fund Project.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Whether time dependency could apply to middle cerebral artery (MCA) M2 occlusion stroke remains unclear.
Objectives
To compare the association of time to EVT and clinical outcomes between large vessel occlusion (LVO) and MCA M2 occlusion patients.
Design
A pool analysis of DEVT (Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients with Acute Ischemic Stroke), RESCUE BT (Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke) and MARVEL (Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke) trial.
Methods
2,846 EVT-treated patients with onset-to-puncture (OTP) ≤24 hours were included. Associations of OTP and onset-to-reperfusion time (OTR) with clinical outcomes were evaluated in patients with LVO and MCA-M2 occlusion separately. The primary effectiveness outcome was 90-day modified Rankin Scale (mRS) score 0–2. Secondary effectiveness outcomes included ordinal mRS score and mRS score 0–1 at 90 days. Safety outcomes were 90-day mortality and symptomatic intracranial hemorrhage within 48 hours.
Results
Among 2,846 eligible patients, 364 had MCA-M2 occlusion. In the LVO group, longer OTP and OTR were consistently associated with worse functional outcomes. In the MCA-M2 group, OTP was not associated with mRS score 0–2 (adjusted odds ratio [aOR] 0.98, 95% confidence interval [CI] 0.94–1.03, P =0.495) or ordinal mRS shift ( P =0.124), although it was associated with lower odds of mRS 0–1 ( P =0.036). Similarly, OTR was not associated with functional independence in MCA-M2 occlusion, but longer OTR was associated with worse ordinal mRS outcomes and lower odds of mRS 0–1.
Conclusions
Treatment delay was consistently associated with worse outcomes after EVT in LVO. In MCA-M2 occlusion, the associations between time metrics and clinical outcomes demonstrated less consistent across different outcome definitions.
Förderung
- the National Natural Science Foundation of China Young Scientists Fund Project
Zitieren
APA
Zhao, X., Zhou, M., Li, L., Zhang, L., Zhu, H., Feng, K., Chen, C., Chen, M., Fan, Y., Yang, Q., Yang, Y., Chen, Y., Heng, G., Ding, C., Song, J., Li, G., & Zi, W. (2026). Time-dependent clinical outcomes of endovascular treatment in acute ischemic stroke due to middle cerebral artery M2 occlusion: A pooled analysis of three randomized controlled trials. Therapeutic Advances in Neurological Disorders, 19. https://doi.org/10.1177/17562864261508450
Vancouver
Zhao X, Zhou M, Li L, Zhang L, Zhu H, Feng K, et al. Time-dependent clinical outcomes of endovascular treatment in acute ischemic stroke due to middle cerebral artery M2 occlusion: A pooled analysis of three randomized controlled trials. Therapeutic Advances in Neurological Disorders. 2026;19. doi:10.1177/17562864261508450
BibTeX
@article{Zhao2026,
author = {Zhao, Xuexiao and Zhou, Mingrui and Li, Linyu and Zhang, Lingyu and Zhu, Haoxuan and Feng, Kaiyuan and Chen, Chunye and Chen, Mingyang and Fan, Yuhan and Yang, Qiuyi and Yang, Yihui and Chen, Yian and Heng, Guanting and Ding, Chawen and Song, Jiaxing and Li, Gaoming and Zi, Wenjie},
title = {Time-dependent clinical outcomes of endovascular treatment in acute ischemic stroke due to middle cerebral artery M2 occlusion: A pooled analysis of three randomized controlled trials},
journal = {Therapeutic Advances in Neurological Disorders},
year = {2026},
volume = {19},
doi = {10.1177/17562864261508450}
}
EUVIMED